{"content":"<li class=\"n-box-item date-title\" data-end=\"1494561599\" data-start=\"1494475200\" data-txt=\"Monday, December 23, 2019\">Thursday, May 11, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3266756\" data-ts=\"1494549585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYBR\" target=\"_blank\">CYBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266756-cyberarkminus-6_4-q1-features-downbeat-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CyberArk -6.4% as Q1 features downbeat profit guidance</a></h4><ul>   <li>CyberArk (NASDAQ:<a href='https://seekingalpha.com/symbol/CYBR' title='CyberArk Software Ltd.'>CYBR</a>) was among Nasdaq's biggest postmarket decliners, <font color='red'>down 6.4%</font>, after <a href=\"https://seekingalpha.com/news/3266624-cyberark-beats-0_05-beats-revenue\" target=\"_blank\">Q1 earnings</a> that beat analyst expectations but featured below-Street profit guidance for the current quarter and full year.</li>    <li>For Q2, it's forecasting revenue of $61M-$62M, vs. $62.4M expected, and non-GAAP EPS of $0.23-$0.25, below consensus for $0.27. For the full year, it sees $268.5M-$271.5M in revenue (vs. consensus for $268.7M) and EPS of $1.18-$1.24 (below consensus for $1.24).</li>    <li>In Q1, total revenue rose 26% to $59M and beat consensus. Operating income was $12.7M on a non-GAAP basis.</li>    <li>Revenue breakout: License, $32.95M (up 19.8%); Maintenance and professional services, $26.1M (up 34.5%).</li>    <li>Cash flow from operations was $16M vs. a year-ago $16.5M; it had $310.6M in cash, equivalents, marketable securities and short-term deposits, vs. $295.5M at Dec. 31.</li>    <li>Today it also said it acquired Conjur, a provider of DevOps security software.</li>    <li><a href=\"https://seekingalpha.com/pr/16830966-cyberark-announces-first-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3266756\" data-linked=\"CyberArk -6.4% as Q1 features downbeat profit guidance\" data-tweet=\"$CYBR - CyberArk -6.4% as Q1 features downbeat profit guidance https://seekingalpha.com/news/3266756-cyberarkminus-6_4-q1-features-downbeat-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3266756-cyberarkminus-6_4-q1-features-downbeat-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266753\" data-ts=\"1494547606\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266753-petrobrasplus-3-on-biggest-profit-in-two-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras +3% on biggest profit in two years</a></h4><ul>   <li>Petrobras (NYSE:<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a>) finished <font color='green'>up 3%</font> after hours after it posted its <a href=\"https://www.wsj.com/articles/petrobras-posts-largest-profit-in-two-years-1494539242\" target=\"_blank\">best profit in two years</a>, with the help of a government allowing it to sell into the domestic market.</li>    <li>The company swung from last year's loss of 1.25B reais to a profit of 4.5B reais, about $1.53B. Sales revenues came to $21.7B (down 2.8%); gross profit was $7.56B.</li>    <li>EBITDA was up 19% to 25.3B reais (about $8.06B).</li>    <li>A rise in crude prices relieved pressure for government subsidy.</li>    <li>Net finance expense was $2.465B; the company managed to reduce total debt to $115.1B from last quarter's $118.4B.</li>    <li><a href=\"http://www.investidorpetrobras.com.br/en/financial-results/holding\" target=\"_blank\">Financial statements</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3266753\" data-linked=\"Petrobras +3% on biggest profit in two years\" data-tweet=\"$PBR - Petrobras +3% on biggest profit in two years https://seekingalpha.com/news/3266753-petrobrasplus-3-on-biggest-profit-in-two-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3266753-petrobrasplus-3-on-biggest-profit-in-two-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266745\" data-ts=\"1494539609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPRT\" target=\"_blank\">WPRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266745-westport-fuel-systemsplus-11_1-after-mid-transformation-earnings-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westport Fuel Systems +11.1% after mid-transformation earnings report</a></h4><ul>   <li>Westport Fuel Systems (<a href=\"http://seekingalpha.com/symbol/WPRT\" target=\"_blank\">WPRT</a> <font color='red'>-2.9%</font>) has regained ground after hours, <font color='green'>up 11.1%</font>, after it posted a Q1 loss that was better than expected, and revenues that missed still more than doubled Y/Y, powered by the merger with Fuel Systems Solutions.</li>    <li>Consolidated gross margin rose to 29.2% from 26.7%, and net loss narrowed to $12.8M from a year-ago loss of $24.5M.</li>    <li>Commercial shipment of Westport HPDI 2.0 technology is on track for later this year, says CEO Nancy Gougarty, providing for a ramp-down of R&amp;D spending and a new revenue stream.</li>    <li>Last month it sold the assets in its Auxiliary Power Unit business and reclassified its Industrial segment into discontinued operations.</li>    <li>Cash and short-term investments came to $47.7M, vs. a previous $24.6M.</li>    <li><a href=\"https://seekingalpha.com/pr/16831044-westport-fuel-systems-reports-first-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3266745\" data-linked=\"Westport Fuel Systems +11.1% after mid-transformation earnings report\" data-tweet=\"$WPRT - Westport Fuel Systems +11.1% after mid-transformation earnings report https://seekingalpha.com/news/3266745-westport-fuel-systemsplus-11_1-after-mid-transformation-earnings-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3266745-westport-fuel-systemsplus-11_1-after-mid-transformation-earnings-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266739\" data-ts=\"1494538521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266739-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk'>TTD</a> <font color='green'>+17.7%</font>. <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color='green'>+7.1%</font>. <a href='https://seekingalpha.com/symbol/HAIN' title='The Hain Celestial Group, Inc.'>HAIN</a> <font color='green'>+6.5%</font>. <a href='https://seekingalpha.com/symbol/CA' title='CA Inc.'>CA</a> <font color='green'>+3.7%</font>. <a href='https://seekingalpha.com/symbol/KIM' title='Kimco Realty Corporation'>KIM</a> <font color='green'>+3.7%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/VJET' title='voxeljet AG'>VJET</a> <font color='red'>-10.8%</font>. <a href='https://seekingalpha.com/symbol/CYBR' title='CyberArk Software Ltd.'>CYBR</a> <font color='red'>-5.7%</font>. <a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='red'>-5.7%</font>. <a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a> <font color='red'>-5.3%</font>. <a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='red'>-4.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266739\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$TTD $NE $HAIN - After Hours Gainers / Losers https://seekingalpha.com/news/3266739-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3266739-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266715\" data-ts=\"1494536298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTD\" target=\"_blank\">TTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266715-trade-desk-up-17-after-hours-on-q1-revenue-beat-guidance-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trade Desk up 17% after hours on Q1 revenue beat &amp; guidance raise</a></h4><ul><li>The Trade Desk (NASDAQ:<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk'>TTD</a>) <a href=\"https://seekingalpha.com/pr/16830926-trade-desk-reports-first-quarter-financial-results\" target=\"_blank\">Q1 results</a> ($M): Revenue: 53.4 (+75.7%).</li><li>Net Income: 4.9 (+590.0%); Non-GAAP Net Income: 7.8 (+122.9%); EPS: 0.11 (+102.5%); Non-GAAP EPS: 0.18 (+100.0%); Non-GAAP EBITDA: 6.3 (+46.5%).</li><li><strong>2017 Guidance</strong>: Revenue: at least $291M from $270M; Non-GAAP EBITDA: $78M from $72M.</li><li><strong>Q2 Guidance</strong>: Revenue: $67M; Non-GAAP EBITDA: $14.5M.</li><li>Shares are up&nbsp;<font color='green'>17%</font>&nbsp;after hours on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266715\" data-linked=\"Trade Desk up 17% after hours on Q1 revenue beat &amp; guidance raise\" data-tweet=\"$TTD - Trade Desk up 17% after hours on Q1 revenue beat &amp; guidance raise https://seekingalpha.com/news/3266715-trade-desk-up-17-after-hours-on-q1-revenue-beat-guidance-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3266715-trade-desk-up-17-after-hours-on-q1-revenue-beat-guidance-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266706\" data-ts=\"1494535764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VJET\" target=\"_blank\">VJET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266706-voxeljet-marks-beat-on-revenue-narrower-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Voxeljet marks beat on revenue, narrower loss</a></h4><ul>   <li>Voxeljet (<a href=\"http://seekingalpha.com/symbol/VJET\" target=\"_blank\">VJET</a> <font color='green'>+9.1%</font>) -- riding high along with 3-D printing peers of late -- beat revenue expectations with its Q1 earnings report and narrowed its net loss.</li>    <li>Revenues were down 7% overall; systems revenues declined with two printers delivered in Q1 vs. a year-ago three printers. Services revenues were up with higher contribution from its German operation, and growth at Voxeljet America.</li>    <li>Total backlog of 3-D printer orders was &euro;4.3M (five printers), vs. a backlog at the end of last quarter of &euro;3.78M (also five printers).</li>    <li>Revenue breakout: Systems revenues, &euro;1.69M (down 39.2%); Services revenues, &euro;2.84M (up 35.9%).</li>    <li>For Q2, it's guiding to revenue of &euro;5.5M-&euro;6.5M, and it reaffirmed its full-year forecast for revenue of &euro;26M-&euro;28M, gross margin over 40%, EBITDA that's neutral to positive, and capex of &euro;8M-&euro;9M.</li>    <li>With relatively thin trading, shares started the postmarket session <font color='green'>up 7.2%</font> but have turned lower, <font color='red'>-15.4%</font>.</li>    <li><a href=\"https://seekingalpha.com/pr/16831007-voxeljet-ag-reports-financial-results-first-quarter-ended-march-31-2017\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3266706\" data-linked=\"Voxeljet marks beat on revenue, narrower loss\" data-tweet=\"$VJET - Voxeljet marks beat on revenue, narrower loss https://seekingalpha.com/news/3266706-voxeljet-marks-beat-on-revenue-narrower-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3266706-voxeljet-marks-beat-on-revenue-narrower-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266695\" data-ts=\"1494535409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCCO\" target=\"_blank\">TCCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266695-technical-communications-reports-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technical Communications reports Q2 results</a></h4><ul><li>Technical Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a>): Q2 EPS of $0.07</li><li>Revenue of $1.39M (+148.2% Y/Y)</li><li>Shares <font color='green'>+26.1%</font>.</li><li><a href='https://seekingalpha.com/pr/16831070-technical-communications-corporation-reports-results-three-six-months-ended-april-1-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3266695\" data-linked=\"Technical Communications reports Q2 results\" data-tweet=\"$TCCO - Technical Communications reports Q2 results https://seekingalpha.com/news/3266695-technical-communications-reports-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3266695-technical-communications-reports-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266694\" data-ts=\"1494535270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTEK\" target=\"_blank\">FTEK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266694-fuel-tech-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fuel Tech reports Q1 results</a></h4><ul><li>Fuel Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/FTEK' title='Fuel Tech, Inc.'>FTEK</a>): Q1 EPS of -$0.11</li><li>Revenue of $8.49M (-52.4% Y/Y)</li><li>Shares <font color='green'>+3.53%</font>.</li><li><a href='https://seekingalpha.com/pr/16831047-fuel-tech-reports-2017-first-quarter-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3266694\" data-linked=\"Fuel Tech reports Q1 results\" data-tweet=\"$FTEK - Fuel Tech reports Q1 results https://seekingalpha.com/news/3266694-fuel-tech-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3266694-fuel-tech-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266680\" data-ts=\"1494534756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VJET\" target=\"_blank\">VJET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266680-voxeljet-q1-top-line-down-7-net-loss-widens-cash-flow-ops-down-33\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Voxeljet Q1 top line down 7%; net loss widens; cash flow ops down 33%</a></h4><ul><li>Thinly traded nano cap voxeljet (NYSE:<a href='https://seekingalpha.com/symbol/VJET' title='voxeljet AG'>VJET</a>) <a href=\"https://seekingalpha.com/pr/16831007-voxeljet-ag-reports-financial-results-first-quarter-ended-march-31-2017\" target=\"_blank\">Q1 result</a>s (&euro;M): 4.5 (-7.0%).</li><li>Net Loss: (2.4) (-22.6%); Loss/Share: (0.65) (-22.6%); Cash Flow Ops: (1.6) (-33.3).</li><li>Revenues from Systems decreased 39% to &euro;1.7M. Two new printers were delivered in the quarter.</li><li>Shares are up&nbsp;<font color='green'>7%</font>&nbsp;after hours, but only on 293 shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266680\" data-linked=\"Voxeljet Q1 top line down 7%; net loss widens; cash flow ops down 33%\" data-tweet=\"$VJET - Voxeljet Q1 top line down 7%; net loss widens; cash flow ops down 33% https://seekingalpha.com/news/3266680-voxeljet-q1-top-line-down-7-net-loss-widens-cash-flow-ops-down-33?source=tweet\" data-url=\"https://seekingalpha.com/news/3266680-voxeljet-q1-top-line-down-7-net-loss-widens-cash-flow-ops-down-33\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266674\" data-ts=\"1494534571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYCC\" target=\"_blank\">CYCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266674-cyclacel-pharmaceuticals-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cyclacel Pharmaceuticals reports Q1 results</a></h4><ul><li>Cyclacel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CYCC' title='Cyclacel Pharmaceuticals, Inc.'>CYCC</a>): Q1 EPS of -$0.38</li><li>Cash and cash equivalents&nbsp;of $12.73M</li><li>Shares <font color='green'>+13.4%</font>.</li><li><a href=\"https://seekingalpha.com/pr/16830987-cyclacel-pharmaceuticals-reports-first-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3266674\" data-linked=\"Cyclacel Pharmaceuticals reports Q1 results\" data-tweet=\"$CYCC - Cyclacel Pharmaceuticals reports Q1 results https://seekingalpha.com/news/3266674-cyclacel-pharmaceuticals-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3266674-cyclacel-pharmaceuticals-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266672\" data-ts=\"1494534437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266672-nordstrom-lower-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordstrom lower after earnings</a></h4><ul> <li>The numbers aren't as bad as some of its counterparts, but Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>) still missed comparable sales estimates with a 0.8% drop in Q1.</li> <li>Gross margin came in at 34.3% of sales vs. 34.7% expected. SG&amp;A expenses fell 70 bps to 32.0% of sales.</li> <li>Online sales were 24% of total sales during the quarter.</li> <li>Nordstrom backs prior guidance for sales growth of 3% to 4% and EPS of $2.75 to $3.00 for the full year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3266622-nordstrom-beats-0_04-beats-revenue\" target=\"_blank\">Nordstrom beats by $0.04, beats on revenue</a> (May 11)</li> <li>JWN <font color='red'>-1.97%</font> AH to $45.30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266672\" data-linked=\"Nordstrom lower after earnings\" data-tweet=\"$JWN - Nordstrom lower after earnings https://seekingalpha.com/news/3266672-nordstrom-lower-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3266672-nordstrom-lower-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266653\" data-ts=\"1494533882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CA\" target=\"_blank\">CA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266653-caplus-2_4-after-steady-q4-beats-consensus-offers-strong-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CA +2.4% after steady Q4 beats consensus, offers strong guidance</a></h4><ul>   <li>CA Technologies (<a href=\"http://seekingalpha.com/symbol/CA\" target=\"_blank\">CA</a> <font color='red'>-0.7%</font>) has <font color='green'>bounced 2.4%</font> in early postmarket action after it <a href=\"https://seekingalpha.com/news/3266649-ca-and-nbsp-technologies-beats-0_05-beats-revenue\" target=\"_blank\">beat earnings expectations</a> and provided a sunny revenue outlook for fiscal 2018.</li>    <li>Revenue of $1.01B (flat) beat an expected $996.6M, and non-GAAP income from continuing operations that declined 10%, to $227M, beat an expected $204.2M.</li>    <li>Total bookings were up 48%, to $1.42B: $1.05B in North American, and $374M international.</li>    <li>Revenue by geography: North America, $683M (flat); International, $329M (flat).</li>    <li>Cash flow from continuing operations came to $419M, down 11% Y/Y.</li>    <li>It's guiding to a 2-3% increase in fiscal 2018 total revenue, to $4.12B-$4.17B (above consensus for $4.04B), and for non-GAAP EPS from continuing operations to fall 3-5%, to $2.35-$2.40 (vs. $2.46 consensus).</li>    <li><a href=\"https://seekingalpha.com/pr/16830968-ca-technologies-reports-fourth-quarter-full-fiscal-year-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3266653\" data-linked=\"CA +2.4% after steady Q4 beats consensus, offers strong guidance\" data-tweet=\"$CA - CA +2.4% after steady Q4 beats consensus, offers strong guidance https://seekingalpha.com/news/3266653-caplus-2_4-after-steady-q4-beats-consensus-offers-strong-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3266653-caplus-2_4-after-steady-q4-beats-consensus-offers-strong-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266649\" data-ts=\"1494533834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CA\" target=\"_blank\">CA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266649-ca-and-nbsp-technologies-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CA&amp;nbsp;Technologies beats by $0.05, beats on revenue</a></h4><ul><li>CA&nbsp;Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/CA' title='CA Inc.'>CA</a>): Q4 EPS of $0.54 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $1.01B (flat Y/Y) <font color='green'>beats by $14.16M</font>.</li><li>Shares <font color='green'>+2.43%</font>.</li><li><a href='https://seekingalpha.com/pr/16830968-ca-technologies-reports-fourth-quarter-full-fiscal-year-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3266649\" data-linked=\"CA&amp;nbsp;Technologies beats by $0.05, beats on revenue\" data-tweet=\"$CA - CA&amp;nbsp;Technologies beats by $0.05, beats on revenue https://seekingalpha.com/news/3266649-ca-and-nbsp-technologies-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3266649-ca-and-nbsp-technologies-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266626\" data-ts=\"1494533334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266626-apricus-biosciences-misses-0_21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apricus Biosciences misses by $0.21</a></h4><ul><li>Apricus Biosciences (APRI): Q1 EPS of $1.04 <font color='red'>misses by $0.21</font>.</li><li>Shares <font color='green'>+11.8%</font>.</li><li><a href=\"https://seekingalpha.com/pr/16830925-apricus-biosciences-provides-corporate-update-first-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3266626\" data-linked=\"Apricus Biosciences misses by $0.21\" data-tweet=\"$SEEL - Apricus Biosciences misses by $0.21 https://seekingalpha.com/news/3266626-apricus-biosciences-misses-0_21?source=tweet\" data-url=\"https://seekingalpha.com/news/3266626-apricus-biosciences-misses-0_21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266621\" data-ts=\"1494533230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDXC\" target=\"_blank\">CDXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266621-chromadex-q1-sales-down-40-shares-off-9-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChromaDex Q1 sales down 40%; shares off 9% after hours</a></h4><ul><li>ChromaDex (NASDAQ:<a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a>) <a href=\"https://seekingalpha.com/pr/16830903-chromadex-reports-first-quarter-2017-financial-results\" target=\"_blank\">Q1 results</a> ($M): 4.4 (-39.7%).</li><li>Net Loss: (1.9) (-733.3%); Loss/Share: (0.05) (-600.0%).</li><li>Sales drop due to loss of largest customer in ingredients business.</li><li>Shares are down&nbsp;<font color='red'>9%</font>&nbsp;after hours on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266621\" data-linked=\"ChromaDex Q1 sales down 40%; shares off 9% after hours\" data-tweet=\"$CDXC - ChromaDex Q1 sales down 40%; shares off 9% after hours https://seekingalpha.com/news/3266621-chromadex-q1-sales-down-40-shares-off-9-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3266621-chromadex-q1-sales-down-40-shares-off-9-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266602\" data-ts=\"1494532405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266602-nvidiaplus-4_5-rbc-capital-boosts-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia +4.5; RBC Capital boosts price target</a></h4><ul>   <li>Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) is <font color='green'>up 4.5%</font> after tagging an all-time high of $130.43 today, continuing a run after its earnings beat that's come to <font color='green'>gains of 24%</font> over the past two days.</li>    <li>Call options are active in the name, Bloomberg notes, with total volume of about 286,000 more than quadruple the 20-day average, with most active contracts being the May calls for $125 and $130.</li>    <li>RBC Capital has just raised its price target to $150, implying 18% upside from today's higher price.</li><li>Earlier, analyst Mitch Steves wrote he was impressed by growing opportunity in data centers as well as growth potential in e-Sports.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266602\" data-linked=\"Nvidia +4.5; RBC Capital boosts price target\" data-tweet=\"$NVDA - Nvidia +4.5; RBC Capital boosts price target https://seekingalpha.com/news/3266602-nvidiaplus-4_5-rbc-capital-boosts-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3266602-nvidiaplus-4_5-rbc-capital-boosts-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266595\" data-ts=\"1494529749\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBT\" target=\"_blank\">GBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266595-global-blood-perks-up-4-after-novo-ceo-declines-comment-potential-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Blood perks up 4% after Novo CEO declines comment about potential deal</a></h4><ul><li>Global Blood Therapeutics (<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color='green'>+3.5%</font>) moves from red to green on below average volume in apparent response to a Reuters interview with Novo Nordisk (<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color='red'>-0.5%</font>) CEO Lars Fruergaard. He declined to comment on an earlier report that his company approached GBT about a deal but couldn't reach agreement on valuation. Investors perceive that his behavior signals that negotiations are still alive.</li><li>Source: The Fly</li><li>Previously: <a href=\"https://seekingalpha.com/news/3250042-new-novo-chief-prowl-acquisitions-stoke-growth\" target=\"_blank\">New Novo chief on the prowl for acquisitions to stoke growth</a> (March 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3266595\" data-linked=\"Global Blood perks up 4% after Novo CEO declines comment about potential deal\" data-tweet=\"$GBT $GBT $NVO - Global Blood perks up 4% after Novo CEO declines comment about potential deal https://seekingalpha.com/news/3266595-global-blood-perks-up-4-after-novo-ceo-declines-comment-potential-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3266595-global-blood-perks-up-4-after-novo-ceo-declines-comment-potential-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266588\" data-ts=\"1494529205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266588-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LPSN' title='LivePerson, Inc.'>LPSN</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CBAK-OLD' title='China BAK Battery, Inc.'>CBAK-OLD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ASUR' title='Asure Software, Inc.'>ASUR</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/OESX' title='Orion Energy Systems, Inc'>OESX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/PEGA' title='Pegasystems Inc.'>PEGA</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OHGI' title='One Horizon Group, Inc.'>OHGI</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='red'>-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266588\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$LPSN $CBAK-OLD $ASUR - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3266588-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3266588-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266581\" data-ts=\"1494526290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266581-yelpplus-2_5-citi-calls-post-earnings-tumble-overdone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp +2.5% as Citi calls post-earnings tumble &#39;overdone&#39;</a></h4><ul>   <li>Yelp (NYSE:<a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a>) is <font color='green'>up 2.5%</font> in its second day of gains after Tuesday's mass post-earnings sell-off, as Citi joins Goldman on the Buy list.</li>    <li>Shares <font color='red'>fell 20.7%</font> on Wednesday after the company <a href=\"https://seekingalpha.com/news/3265568-yelp-slides-28_4-percent-chops-2017-guidance\" target=\"_blank\">cut its outlook</a> on revenue and EBITDA for the year.</li>    <li>That decline is \"overdone,\" says analyst Mark May, and the valuation looks good now at two times enterprise value/sales.</li>    <li>The company's had success in reducing churn, and sales force hiring, retention and productivity have rebounded, he notes.</li>    <li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3265815-goldman-steps-yelps-plunge\" target=\"_blank\">Goldman steps into Yelp's plunge</a> (May. 10 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266581\" data-linked=\"Yelp +2.5% as Citi calls post-earnings tumble &#39;overdone&#39;\" data-tweet=\"$YELP - Yelp +2.5% as Citi calls post-earnings tumble &#39;overdone&#39; https://seekingalpha.com/news/3266581-yelpplus-2_5-citi-calls-post-earnings-tumble-overdone?source=tweet\" data-url=\"https://seekingalpha.com/news/3266581-yelpplus-2_5-citi-calls-post-earnings-tumble-overdone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266579\" data-ts=\"1494525942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DEST\" target=\"_blank\">DEST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266579-retail-outlier-destination-maternityplus-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail outlier Destination Maternity +10%</a></h4><ul><li>On a day that the mall sector is getting hammered, shares of Destination Maternity (NASDAQ:<a href='https://seekingalpha.com/symbol/DEST' title='Destination Maternity Corporation'>DEST</a>) are&nbsp;<font color='green'>up 10.21%&nbsp;</font>on volume 3X normal activity.</li><li>The company hasn't issued any press releases or SEC filings, so the buying action looks speculative in nature.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3266505-retail-stocks-torched-macys-lights-fuse\" target=\"_blank\">Retail stocks torched after Macy's lights the fuse</a> (May 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3266579\" data-linked=\"Retail outlier Destination Maternity +10%\" data-tweet=\"$DEST - Retail outlier Destination Maternity +10% https://seekingalpha.com/news/3266579-retail-outlier-destination-maternityplus-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3266579-retail-outlier-destination-maternityplus-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266575\" data-ts=\"1494525603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266575-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SD' title='SandRidge Energy, Inc.'>SD</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ASIX' title='AdvanSix Inc.'>ASIX</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/REI' title='Ring Energy, Inc.'>REI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/UEC' title='Uranium Energy Corp'>UEC</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/ASM' title='Avino Silver & Gold Mines Ltd'>ASM</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/GST' title='Gastar Exploration Inc.'>GST</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266575\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$SD $ASIX $REI - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3266575-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3266575-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266574\" data-ts=\"1494525019\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCS\" target=\"_blank\">BCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266574-reuters-barclays-shuffles-leaders-will-hire-in-investment-bank\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Barclays shuffles leaders, will hire in investment bank</a></h4><ul>   <li>Barclays (<a href=\"http://seekingalpha.com/symbol/BCS\" target=\"_blank\">BCS</a> <font color='red'>-2%</font>) is <a href=\"http://www.reuters.com/article/us-barclays-investment-bank-exclusive-idUSKBN18728C\" target=\"_blank\">rearranging leadership</a> in its global investment banking operation, and will look to hire 50-100 new people to boost efforts there, Reuters reports.</li>    <li>Recently named bank chief Tim Throsby will be interim head of its markets division; that division's former leader, Joe Corcoran, will take a new position as vice chairman of markets.</li>    <li>Meanwhile, Joe McGrath will be global head of banking, with John Miller reporting to him as head of global industry coverage banking.</li>    <li>The markets business had a weak showing in Q1 results, which CEO Jes Staley blamed on weakness in the U.S. rates business and a tough Y/Y comparison.</li>    <li>The new hires will focus on key areas including rates trading, foreign exchange and also equities, Reuters said.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266574\" data-linked=\"Reuters: Barclays shuffles leaders, will hire in investment bank\" data-tweet=\"$BCS - Reuters: Barclays shuffles leaders, will hire in investment bank https://seekingalpha.com/news/3266574-reuters-barclays-shuffles-leaders-will-hire-in-investment-bank?source=tweet\" data-url=\"https://seekingalpha.com/news/3266574-reuters-barclays-shuffles-leaders-will-hire-in-investment-bank\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266566\" data-ts=\"1494523781\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRT\" target=\"_blank\">SRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266566-startek-q1-earnings-beat-propels-shares-up-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">StarTek Q1 earnings beat propels shares, up 20%</a></h4><ul><li>Thinly traded micro cap StarTek (<a href='https://seekingalpha.com/symbol/SRT' title='StarTek, Inc.'>SRT</a> <font color='green'>+20.3%</font>) heads north on more than a 4x surge in volume, albeit on turnover of only 156K shares, on the heels of its <a href=\"https://seekingalpha.com/pr/16829197-startek-reports-first-quarter-2017-results\" target=\"_blank\">Q1 results</a>. EPS of $0.11 beat consensus of $0.05 but revenues of $77.7M fell short by $2.1M.</li><li>Results ($M): Revenue: 77.7 (-0.4%), Net Income: 1.8 (+999%); EPS: 0.11 (+999%); Cash Flow Ops: 7.2 (+47.7%); Non-GAAP EBITDA: 5.4 (+26.6%).</li><li>Consensus views for Q2 and 2017 are EPS of $0.05 and $0.26 on revenues of $77.3M and and $333.9M, respectively.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266566\" data-linked=\"StarTek Q1 earnings beat propels shares, up 20%\" data-tweet=\"$SRT - StarTek Q1 earnings beat propels shares, up 20% https://seekingalpha.com/news/3266566-startek-q1-earnings-beat-propels-shares-up-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3266566-startek-q1-earnings-beat-propels-shares-up-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266564\" data-ts=\"1494523198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LAUR\" target=\"_blank\">LAUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266564-post-earnings-strength-for-laureate-education\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings strength for Laureate Education</a></h4><ul>     <li>Laureate Education (<a href='https://seekingalpha.com/symbol/LAUR' title='Laureate Education'>LAUR</a> <font color='green'>+8.8%</font>) rallies after Q1 sales top estimates.</li>     <li>The company reports total enrollment was up 2% to 1.085M students. New enrollment fell 2% during the quarter.</li>     <li>Looking ahead, Laureate sees total enrollment growth of 2.0% to 3.5% to a range of 1.064M to 1.080M students. Adjusted EBITDA is expected to fall in a range of $789M to $804M.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3266340-laureate-education-misses-0_09-beats-revenue\" target=\"_blank\">Laureate Education misses by $0.09, beats on revenue</a> (May 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266564\" data-linked=\"Post-earnings strength for Laureate Education\" data-tweet=\"$LAUR - Post-earnings strength for Laureate Education https://seekingalpha.com/news/3266564-post-earnings-strength-for-laureate-education?source=tweet\" data-url=\"https://seekingalpha.com/news/3266564-post-earnings-strength-for-laureate-education\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266563\" data-ts=\"1494522841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNET\" target=\"_blank\">RNET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266563-rignetminus-1_8-files-shelf-for-4_75m-share-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RigNet -1.8% as it files shelf for 4.75M-share secondary</a></h4><ul>   <li>RigNet (NASDAQ:<a href='https://seekingalpha.com/symbol/RNET' title='RigNet'>RNET</a>) is <font color='red'>off 1.8%</font> after it filed a <a href=\"https://seekingalpha.com/filing/3544613\" target=\"_blank\">4.75M-share shelf registration</a> for a secondary offering by an existing shareholder.</li>    <li>The registration, covering $200M aggregate price total, names a proposed maximum offering price per unit in the secondary of $17.70, for an aggregate price of $84.075M. Shares are now down to $17.62 in Nasdaq trading.</li>    <li>The company won't receive proceeds of any sale by the selling stockholder.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266563\" data-linked=\"RigNet -1.8% as it files shelf for 4.75M-share secondary\" data-tweet=\"$RNET - RigNet -1.8% as it files shelf for 4.75M-share secondary https://seekingalpha.com/news/3266563-rignetminus-1_8-files-shelf-for-4_75m-share-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/3266563-rignetminus-1_8-files-shelf-for-4_75m-share-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266560\" data-ts=\"1494522409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266560-financials-top-5-gainers-losers-of-1-05-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:05 PM</a></h4><ul><li><b>Gainers:</b> WAC <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/MBI' title='MBIA Inc.'>MBI</a> <font color='green'>+9%</font>.<a href='https://seekingalpha.com/symbol/SNC' title='State National Companies, Inc.'>SNC</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NYRT' title='New York REIT'>NYRT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/INTL' title='INTL FCStone Inc.'>INTL</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AEG' title='AEGON NV'>AEG</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ABR' title='Arbor Realty Trust, Inc.'>ABR</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266560\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:05 PM\" data-tweet=\"$DHCP $MBI $SNC - Financials - Top 5 Gainers / Losers as of 1:05 PM https://seekingalpha.com/news/3266560-financials-top-5-gainers-losers-of-1-05-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3266560-financials-top-5-gainers-losers-of-1-05-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266554\" data-ts=\"1494521544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266554-teva-to-jettison-womens-health-and-european-oncology-and-pain-units-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva to jettison women&#39;s health and European oncology and pain units; shares ahead 2%</a></h4><ul><li>During its Q1 earnings call, Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='green'>+1.9%</font>) interim CEO Yitzhak Peterburg <a href=\"http://www.fiercepharma.com/pharma/teva-officially-scouts-women-s-health-cancer-sales-as-world-class-ceo-search-continues\" target=\"_blank\">confirmed </a>that the company intends to shop its women's heath and European oncology and pain businesses in order to raise cash to pay down debt. He added that the divestments, together with future asset sales, will be \"significantly in excess\" of $1B.</li><li>The company's search for a new permanent CEO is \"moving along very well.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3266554\" data-linked=\"Teva to jettison women&#39;s health and European oncology and pain units; shares ahead 2%\" data-tweet=\"$TEVA - Teva to jettison women&#39;s health and European oncology and pain units; shares ahead 2% https://seekingalpha.com/news/3266554-teva-to-jettison-womens-health-and-european-oncology-and-pain-units-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3266554-teva-to-jettison-womens-health-and-european-oncology-and-pain-units-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266553\" data-ts=\"1494521073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266553-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color='green'>+47%</font>. <a href='https://seekingalpha.com/symbol/RELY' title='Real Industry, Inc.'>RELY</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/SRT' title='StarTek, Inc.'>SRT</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/LPSN' title='LivePerson, Inc.'>LPSN</a> <font color='green'>+20%</font>. WAC <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/GNVC' title='GenVec, Inc.'>GNVC</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CBAK-OLD' title='China BAK Battery, Inc.'>CBAK-OLD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PEGA' title='Pegasystems Inc.'>PEGA</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ASUR' title='Asure Software, Inc.'>ASUR</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> ITUS <font color='red'>-37%</font>. <a href='https://seekingalpha.com/symbol/OHGI' title='One Horizon Group, Inc.'>OHGI</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/AVNW' title='Aviat Networks, Inc.'>AVNW</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a> <font color='red'>-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266553\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SGMO $RELY $SRT - Midday Gainers / Losers https://seekingalpha.com/news/3266553-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3266553-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266549\" data-ts=\"1494520916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RELY\" target=\"_blank\">RELY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266549-real-industry-q1-revenue-beat-gooses-shares-up-31\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Real Industry Q1 revenue beat gooses shares, up 31%</a></h4><ul><li>Holding company Real Industry (<a href='https://seekingalpha.com/symbol/RELY' title='Real Industry, Inc.'>RELY</a> <font color='green'>+30.6%</font>) is up on more than a 40% spike in volume on the heels of its <a href=\"https://seekingalpha.com/pr/16829359-real-industry-reports-fiscal-2017-first-quarter-results\" target=\"_blank\">Q1 results</a>.</li><li>Revenues: $337.1 (+9.0%); Net Loss: ($12.2) (-13.0%); Loss/share: (0.43) (-13.2%). Revenue growth was driven by an 8% shift in mix from tolling to buy/sell volume.</li><li><strong>Q2 outlook</strong>: Non-GAAP EBITDA for RANA and RAEU should be higher than Q1, scrap flow in North America showing signs of improvement, LME and aluminum alloy prices continue to rise.</li><li>Consensus views for Q2 and 2017 are losses/share of ($0.27) and ($1.14) on revenues of $328.3M and $1.3B, respectively</li></ul><div class=\"tiny-share-widget\" data-id=\"3266549\" data-linked=\"Real Industry Q1 revenue beat gooses shares, up 31%\" data-tweet=\"$RELY - Real Industry Q1 revenue beat gooses shares, up 31% https://seekingalpha.com/news/3266549-real-industry-q1-revenue-beat-gooses-shares-up-31?source=tweet\" data-url=\"https://seekingalpha.com/news/3266549-real-industry-q1-revenue-beat-gooses-shares-up-31\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266546\" data-ts=\"1494519695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANIX\" target=\"_blank\">ANIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266546-itus-launches-public-offering-of-common-stock-1_05-shares-down-38\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ITUS launches public offering of common stock at $1.05; shares down 38%</a></h4><ul><li>Thinly traded nano cap ITUS Corp. (ITUS <font color='red'>-38.2%</font>) <a href=\"https://seekingalpha.com/pr/16830038-itus-corporation-announces-pricing-public-offering-3_5-million-shares-common-stock\" target=\"_blank\">prices </a>its \"best efforts\" public offering of 3.5M shares of common stock at $1.05. Closing date is May 16.</li><li>Net proceeds will fund working capital and general corporate purposes.</li><li>Yesterday's close was $1.70.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266546\" data-linked=\"ITUS launches public offering of common stock at $1.05; shares down 38%\" data-tweet=\"$ANIX - ITUS launches public offering of common stock at $1.05; shares down 38% https://seekingalpha.com/news/3266546-itus-launches-public-offering-of-common-stock-1_05-shares-down-38?source=tweet\" data-url=\"https://seekingalpha.com/news/3266546-itus-launches-public-offering-of-common-stock-1_05-shares-down-38\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266537\" data-ts=\"1494518501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266537-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CYRX' title='CryoPort, Inc.'>CYRX</a> <font color='green'>+6%</font>.</li>     <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SANW' title='S&W Seed Co'>SANW</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266537\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$WATT $CYRX $WKHS - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3266537-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3266537-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266533\" data-ts=\"1494517458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266533-neovasc-q1-revenue-miss-pressures-shares-down-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neovasc Q1 revenue miss pressures shares, down 10%</a></h4><ul><li>Neovasc (<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color='red'>-10%</font>) slumps on below average volume after its Q1 revenue of ~$1.5M (-26.2%) <a href=\"https://seekingalpha.com/pr/16829113-neovasc-announces-results-first-quarter-2017\" target=\"_blank\">missed consensus</a> of $2.6M. The bulk of sales was generated through consulting services ($1.1B) instead of product. Reducer sales were $260K.</li><li>Consensus revenues expectations for Q2 and 2017 are $2.8M and $12.4M, respectively.</li><li>The Tiara replacement valve has been implanted in 28 patients. The 30-day survival rate is 88% (n=23/26) with no 30-day deaths in any of the last 17 recipients.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266533\" data-linked=\"Neovasc Q1 revenue miss pressures shares, down 10%\" data-tweet=\"$NVCN - Neovasc Q1 revenue miss pressures shares, down 10% https://seekingalpha.com/news/3266533-neovasc-q1-revenue-miss-pressures-shares-down-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3266533-neovasc-q1-revenue-miss-pressures-shares-down-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266530\" data-ts=\"1494517117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEF\" target=\"_blank\">TEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266530-telefonicaminus-4_7-profits-rise-miss-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telefonica -4.7% as profits rise but miss expectations</a></h4><ul>   <li>Telefonica (NYSE:<a href='https://seekingalpha.com/symbol/TEF' title='Telefonica S.A.'>TEF</a>) is <font color='red'>4.4% lower</font> in NYSE trading after a <a href=\"https://seekingalpha.com/news/3266265-telefonica-s-reports-q1-results\" target=\"_blank\">Q1 miss</a> despite profits that rose nearly 5%.</li>    <li>Revenues of &euro;13.13B were down 4.3% sequentially but rose 5% Y/Y amid price increases in the company's major markets.</li>    <li>OIBDA hit &euro;4.02B, up 4.8% Y/Y on stable margins.</li>    <li>The company pointed to improved quality in its customer base, with LTE customers up 1.7 times, smartphones up 18% and FTTx/cable up 21%.</li>    <li>In regional results, revenue fell 2.6% to &euro;3.07B in its key Spanish market on lower service revenues (-1.5%) and lower handset sales (-29.9%). OIBDA there was down 2.4%. In Germany, revenues fell 4.7% to &euro;1.77B. Meanwhile, in the UK, revenues were up 2.1% to &euro;1.6B, and revenues for Telefonica Brasil rose 1.6% to &euro;3.17B.</li>    <li>Free cash flow -- a turnaround focus for Chairman Jos&eacute; Mar&iacute;a &Aacute;lvarez-Pallete -- jumped to &euro;599M from a year-ago &euro;69M.</li>    <li><a href=\"https://seekingalpha.com/pr/16829625-telefonica-s-net-income-increased-42_2-percent-reaching-779-million-euros-first-quarter-year\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3266530\" data-linked=\"Telefonica -4.7% as profits rise but miss expectations\" data-tweet=\"$TEF - Telefonica -4.7% as profits rise but miss expectations https://seekingalpha.com/news/3266530-telefonicaminus-4_7-profits-rise-miss-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3266530-telefonicaminus-4_7-profits-rise-miss-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266528\" data-ts=\"1494516276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266528-omeros-q1-top-line-up-66-omidria-sales-miss-consensus-shares-down-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omeros Q1 top line up 66%, but Omidria sales miss consensus; shares down 11%</a></h4><ul><li>Omeros (<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='red'>-10.5%</font>) <a href=\"https://seekingalpha.com/pr/16829161-omeros-corporation-reports-first-quarter-2017-financial-results\" target=\"_blank\">Q1 results</a> ($M): Total Revenues: 12.3 (+66.2%); OMIDRIA sales: 12.3 (+70.8%).</li><li>Net Loss: (15.1) (+26.4%); Loss/Share: (0.34) (+37.0%).</li><li>OMIDRIA sales decreased $648K sequentially due to timing of wholesale orders.</li><li>Q2 and full-year revenue expectations are $15.3M and $77.3M, respectively.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266528\" data-linked=\"Omeros Q1 top line up 66%, but Omidria sales miss consensus; shares down 11%\" data-tweet=\"$OMER - Omeros Q1 top line up 66%, but Omidria sales miss consensus; shares down 11% https://seekingalpha.com/news/3266528-omeros-q1-top-line-up-66-omidria-sales-miss-consensus-shares-down-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3266528-omeros-q1-top-line-up-66-omidria-sales-miss-consensus-shares-down-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266525\" data-ts=\"1494515608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNKD\" target=\"_blank\">MNKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266525-mannkind-q1-revenue-disappoints-shares-down-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MannKind Q1 revenue disappoints, shares down 15%</a></h4><ul><li>MannKind (<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-14.7%</font>) <a href=\"https://seekingalpha.com/pr/16829221-mannkind-corporation-reports-2017-first-quarter-financial-results\" target=\"_blank\">Q1 results</a> ($M): Revenue: 3.0, Commercial Product Sales: 1.2, Bulk Insulin Sales: 1.8.</li><li>Net Loss: (16.3) (+34.5%); Loss/Share: (0.17) (+41.4%).</li><li>FDA decision on Afrezza labeling update expected by September 30.</li><li>Investors are expecting some daylight regarding Afrezza sales. Consensus view for Q2 and full-year are $2.8M and $28M, respectively.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266525\" data-linked=\"MannKind Q1 revenue disappoints, shares down 15%\" data-tweet=\"$MNKD - MannKind Q1 revenue disappoints, shares down 15% https://seekingalpha.com/news/3266525-mannkind-q1-revenue-disappoints-shares-down-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3266525-mannkind-q1-revenue-disappoints-shares-down-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266523\" data-ts=\"1494515067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KELYA\" target=\"_blank\">KELYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266523-on-kelly-services-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Kelly Services&#39; Q1</a></h4><ul><li>Kelly Services (<a href='https://seekingalpha.com/symbol/KELYA' title='Kelly Services, Inc.'>KELYA</a> <font color='green'>+5.7%</font>)&nbsp;reports revenue fell 4.2% on a constant&nbsp;currency basis in <a href=\"https://seekingalpha.com/pr/16829857-kelly-services-r-reports-first-quarter-earnings\" target=\"_blank\">Q1</a>.</li><li>Total Americas revenue from services up 1.6% to $1.04B (+1.5%&nbsp;on a constant currency basis).</li><li>Total EMEA revenue from services rose 7.3% to $241M (+9.2%&nbsp;on a constant currency basis).</li><li>Gross margin rate improved 70 bps to 18%.</li><li>SG&amp;A expense rate grew 50 bps to 16.7%.</li><li>Operating margin rate expanded 20 bps to 1.3%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266523\" data-linked=\"More on Kelly Services&#39; Q1\" data-tweet=\"$KELYA - More on Kelly Services&#39; Q1 https://seekingalpha.com/news/3266523-on-kelly-services-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3266523-on-kelly-services-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266497\" data-ts=\"1494515000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266497-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color='green'>+45%</font>. <a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/GNVC' title='GenVec, Inc.'>GNVC</a> <font color='green'>+15%</font>. NEOT <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AST' title='Asterias Biotherapeutics, Inc.'>AST</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/AGTC' title='Applied Genetic Technologies Corporation'>AGTC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CFMS' title='ConforMIS'>CFMS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266497\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$SGMO $XON $GNVC - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3266497-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3266497-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266522\" data-ts=\"1494514992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMCBF\" target=\"_blank\">HMCBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266522-reuters-home-capital-looking-to-sell-c-2b-in-assets-shares-up-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Home Capital looking to sell C$2B in assets; shares up 14%</a></h4><ul><li>Details are limited at the moment, but the Canadian lender (<a href='https://seekingalpha.com/symbol/HMCBF' title='Home Capital Group Inc.'>OTCPK:HMCBF</a>) is looking shed C$2B in assets in the hope of staving off a forced sale of the company.</li><li>Shares are&nbsp;<font color='green'>up more than 14%</font>&nbsp;in Toronto.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266522\" data-linked=\"Reuters: Home Capital looking to sell C$2B in assets; shares up 14%\" data-tweet=\"$HMCBF - Reuters: Home Capital looking to sell C$2B in assets; shares up 14% https://seekingalpha.com/news/3266522-reuters-home-capital-looking-to-sell-c-2b-in-assets-shares-up-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3266522-reuters-home-capital-looking-to-sell-c-2b-in-assets-shares-up-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266513\" data-ts=\"1494514225\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAAS\" target=\"_blank\">CAAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266513-on-china-automitive-systems-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on China Automitive System&#39;s Q1</a></h4><ul><li>China Automotive Systems (<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a> <font color='red'>-3.2%</font>)&nbsp;reports sales rose 2.1% in <a href=\"https://seekingalpha.com/pr/16829721-china-automotive-systems-reports-2017-first-quarter-results\" target=\"_blank\">Q1</a>&nbsp;mainly due to the increased sales volume.</li><li>Gross margin rate +10 bps to 18.1%.</li><li>Selling expense rate improved 30 bps to 3.4%.</li><li>Operating margin rate grew 10 bps to 6.1%.</li><li>The company expects FY2017 revenue of $485M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266513\" data-linked=\"More on China Automitive System&#39;s Q1\" data-tweet=\"$CAAS - More on China Automitive System&#39;s Q1 https://seekingalpha.com/news/3266513-on-china-automitive-systems-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3266513-on-china-automitive-systems-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266512\" data-ts=\"1494514109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANF\" target=\"_blank\">ANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266512-wunderlich-not-buying-abercrombie-fitch-m-buzz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wunderlich not buying the Abercrombie &amp; Fitch M&amp;A buzz</a></h4><ul> <li>Wunderlich Securities is selling the news that Abercrombie &amp; Fitch (NYSE:<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a>) is looking to sell itself.</li> <li>Analyst Eric Beder's <a href=\"http://www.barrons.com/articles/abercrombie-fitch-dont-believe-the-hype-1494509583\" target=\"_blank\">brutal assessment</a> is posted below.</li> <li>\"Frankly, given: 1) the continued free fall at Abercrombie, 2) a history of mergers in the specialty retailing sector not working, and 3) a brutal operating environment, we believe the potential, especially for a material premium for ANF, is minimal and we see little potential for a transaction at the current time. As such, we are lowering our rating to Sell and would advise investors to take profits on the \"transaction hype,\" writes Beder.</li> <li>Shares of ANF are&nbsp;<font color='red'>down 0.56%</font>&nbsp;on the day, which stacks up favorably amid a mall sector meltdown.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3265976-abercrombie-and-fitch-suitors-said-include-american-eagle-express\" target=\"_blank\">Abercrombie &amp; Fitch suitors said to include American Eagle and Express</a> (May 10)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3266464-abercrombie-and-fitch-confirms-talks-suitors\" target=\"_blank\">Abercrombie &amp; Fitch confirms talks with suitors</a> (May 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266512\" data-linked=\"Wunderlich not buying the Abercrombie &amp; Fitch M&amp;A buzz\" data-tweet=\"$ANF - Wunderlich not buying the Abercrombie &amp; Fitch M&amp;A buzz https://seekingalpha.com/news/3266512-wunderlich-not-buying-abercrombie-fitch-m-buzz?source=tweet\" data-url=\"https://seekingalpha.com/news/3266512-wunderlich-not-buying-abercrombie-fitch-m-buzz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266510\" data-ts=\"1494513152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BITA\" target=\"_blank\">BITA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266510-bitautominus-5_4-on-bottom-line-q1-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitauto -5.4% on bottom-line Q1 miss</a></h4><ul>   <li>Bitauto (NYSE:<a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a>) is <font color='red'>5.4% lower</font> this morning after its <a href=\"https://seekingalpha.com/news/3266329-bitauto-misses-0_02-beats-revenue\" target=\"_blank\">Q1 results</a> missed expectations despite doubling net income.</li>    <li>Revenue rose 43% driven almost entirely by increased transaction volume.</li>    <li>Gross profit was up 38.3% to 1.03B yuan (about $149.1M), and loss from operations narrowed to 10.9M yuan (about $1.6M) from a previous loss of 66.5M yuan.</li>    <li>Revenue by segment: advertising and subscriptions, 744.9M yuan ($108.2M), up 4.2%; transaction services, 625.8M yuan ($90.9M), up 193.5%; digital marketing solutions, 174.8M yuan ($25.4M), up 4.3%.</li>    <li>For Q2, it's guiding to revenue of 1.83B-1.88B yuan ($265.9M-$273.1M, above consensus for $262.1M), a 30.4%-34% increase Y/Y.</li>    <li><a href=\"https://seekingalpha.com/pr/16829750-bitauto-announces-first-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3266510\" data-linked=\"Bitauto -5.4% on bottom-line Q1 miss\" data-tweet=\"$BITA - Bitauto -5.4% on bottom-line Q1 miss https://seekingalpha.com/news/3266510-bitautominus-5_4-on-bottom-line-q1-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3266510-bitautominus-5_4-on-bottom-line-q1-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266507\" data-ts=\"1494512993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYRT\" target=\"_blank\">NYRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266507-new-york-reit-down-nearly-10-after-liquidation-update-macys-woes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New York REIT down nearly 10% after liquidation update, Macy&#39;s woes</a></h4><ul><li>The company is in the process of liquidating, <a href=\"https://seekingalpha.com/pr/16829387-new-york-reit-announces-results-first-quarter-2017\" target=\"_blank\">and in its Q1 update</a> last night said it expects liquidating distributions of about $9.25 per share, perhaps a bit shy of what investors were hoping for.</li><li>There's also a&nbsp;<font color='red'>13.5% tumble</font>&nbsp;in Macy's - a tenant of New York REIT (NYSE:<a href='https://seekingalpha.com/symbol/NYRT' title='New York REIT'>NYRT</a>) - <a href=\"https://seekingalpha.com/news/3266489-mall-stocks-fall-sales-dud-macys\" target=\"_blank\">after its weak sales report</a>.</li><li>NYRT<font color='red'> -9.85%</font>&nbsp;to $8.73.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266507\" data-linked=\"New York REIT down nearly 10% after liquidation update, Macy&#39;s woes\" data-tweet=\"$NYRT - New York REIT down nearly 10% after liquidation update, Macy&#39;s woes https://seekingalpha.com/news/3266507-new-york-reit-down-nearly-10-after-liquidation-update-macys-woes?source=tweet\" data-url=\"https://seekingalpha.com/news/3266507-new-york-reit-down-nearly-10-after-liquidation-update-macys-woes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266504\" data-ts=\"1494512736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRBP\" target=\"_blank\">CRBP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266504-enrollment-completed-in-corbus-pharmas-mid-stage-study-of-anabasum-in-rare-autoimmune\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enrollment completed in Corbus Pharma&#39;s mid-stage study of anabasum in rare autoimmune connective tissue disorder; shares ahead 3%</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/16829959-corbus-pharmaceuticals-announces-last-subject-enrolled-phase-2-study-anabasum-treatment-skin\" target=\"_blank\">last patient has been enrolled</a> in Corbus Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a> <font color='green'>+2.5%</font>) <a href=\"https://clinicaltrials.gov/ct2/show/NCT02466243?term=jbt-101&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> assessing anabasum (formerly JBT-101) for the treatment of skin-predominant <a href=\"http://www.corbuspharma.com/pipeline/dermatomyositis\" target=\"_blank\">dermatomyositis</a>, a rare progressive autoimmune disorder characterized by painful skin abnormalities including excessive fluid accumulation in body tissues and scaling and degenerative changes around the knuckles, elbows and knees.</li><li>According to ClinicalTrials.gov, the estimated final data collection date for the primary endpoint was December 2016 but it now appears to be Q3 of next year (112-day treatment period in Part &nbsp;A + 364-day treatment and follow-up in Part B).</li></ul><div class=\"tiny-share-widget\" data-id=\"3266504\" data-linked=\"Enrollment completed in Corbus Pharma&#39;s mid-stage study of anabasum in rare autoimmune connective tissue disorder; shares ahead 3%\" data-tweet=\"$CRBP - Enrollment completed in Corbus Pharma&#39;s mid-stage study of anabasum in rare autoimmune connective tissue disorder; shares ahead 3% https://seekingalpha.com/news/3266504-enrollment-completed-in-corbus-pharmas-mid-stage-study-of-anabasum-in-rare-autoimmune?source=tweet\" data-url=\"https://seekingalpha.com/news/3266504-enrollment-completed-in-corbus-pharmas-mid-stage-study-of-anabasum-in-rare-autoimmune\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266505\" data-ts=\"1494512700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNA\" target=\"_blank\">ASNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266505-retail-stocks-torched-after-macys-lights-fuse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail stocks torched after Macy&#39;s lights the fuse</a></h4><ul>     <li>There's an uneasy feeling in retail as the mall story takes another dark turn with new numbers out from Macy's.</li>     <li>Ascena Retail Group (<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='red'>-8.7%</font>), Tailored Brands (<a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc'>TLRD</a> <font color='red'>-7.8%</font>), Francesca's (<a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a> <font color='red'>-6.9%</font>), DSW (<a href='https://seekingalpha.com/symbol/DSW' title='DSW Inc.'>DSW</a> <font color='red'>-7.3%</font>), Chico's (<a href='https://seekingalpha.com/symbol/FAS' title='Direxion Daily Financial Bull 3x Shares ETF'>FAS</a> <font color='red'>-3.1%</font>), L Brands (<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='red'>-5.4%</font>), Boot Barn (<a href='https://seekingalpha.com/symbol/BOOT' title='Boot Barn Holdings'>BOOT</a> <font color='red'>-6.3%</font>), Stein Mart (<a href='https://seekingalpha.com/symbol/SMRT' title='Stein Mart, Inc.'>SMRT</a> <font color='red'>-4.7%</font>), Shoe Carnival (<a href='https://seekingalpha.com/symbol/SCVL' title='Shoe Carnival, Inc.'>SCVL</a> <font color='red'>-5%</font>), Citi Trends (<a href='https://seekingalpha.com/symbol/CTRN' title='Citi Trends, Inc.'>CTRN</a> <font color='red'>-3.8%</font>), Stage Stores (<a href='https://seekingalpha.com/symbol/SSI' title='Stage Stores, Inc.'>SSI</a> <font color='red'>-3.8%</font>) and The Children's Place (<a href='https://seekingalpha.com/symbol/PLCE' title='The Children&#39;s Place Retail Stores, Inc.'>PLCE</a> <font color='red'>-1.4%</font>) join the list of decliners reported on earlier.</li>     <li>Discounters are also in harm's way, with Fred's (<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='red'>-6%</font>), Big Lots (<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a> <font color='red'>-3.9%</font>), Dollar General (<a href='https://seekingalpha.com/symbol/DG' title='Dollar General Corporation'>DG</a> <font color='red'>-2.2%</font>) and Dollar Tree (<a href='https://seekingalpha.com/symbol/DLTR' title='Dollar Tree, Inc.'>DLTR</a> <font color='red'>-2.1%</font>) all lower.</li>     <li>Target (NYSE:<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a>) is <font color='red'>down 3.20%</font>, while Wal-Mart (NYSE:<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a>) and Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) are <font color='red'>off 0.6%</font> just like the S&amp;P 500 Index.</li>     <li>Companies that make clothes are also reeling, led by G-III Apparel (<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a> <font color='red'>-8.2%</font>), Caleres (<a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a> <font color='red'>-5.6%</font>), Oxford Industries (<a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries Inc.'>OXM</a> <font color='red'>-5.4%</font>), Vera Bradley (<a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a> <font color='red'>-4.9%</font>), Skechers (<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='red'>-3.9%</font>), Ralph Lauren (<a href='https://seekingalpha.com/symbol/RL' title='Ralph Lauren Corporation'>RL</a> <font color='red'>-5%</font>) and Wolverine World Wide (<a href='https://seekingalpha.com/symbol/WWW' title='Wolverine World Wide Inc.'>WWW</a> <font color='red'>-4.9%</font>).</li>     <li>No joy in sports apparel: Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a>) and Under Armour (NYSE:<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>) are both <font color='red'>down about 1.75%,&nbsp;</font>, while Finish Line (<a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a> <font color='red'>-7.4%</font>) and Foot Locker (<a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='red'>-3.2%</font>) are in a sharp retreat.</li>     <li>There's no way for the S&amp;P Retail (NYSEARCA:<a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>) to avoid the carnage, the catch-all is <font color='red'>down 2.77%</font> on the day.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3266489-mall-stocks-fall-sales-dud-macys\" target=\"_blank\">Mall stocks fall after sales dud from Macy's</a> (May 11)</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3266494-retail-landlords-pressure-following-weak-macys-kohls-numbers\" target=\"_blank\">Retail landlords under pressure following weak Macy's, Kohl's numbers</a> (May 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266505\" data-linked=\"Retail stocks torched after Macy&#39;s lights the fuse\" data-tweet=\"$ASNA $ASNA $TLRD - Retail stocks torched after Macy&#39;s lights the fuse https://seekingalpha.com/news/3266505-retail-stocks-torched-after-macys-lights-fuse?source=tweet\" data-url=\"https://seekingalpha.com/news/3266505-retail-stocks-torched-after-macys-lights-fuse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>103&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266501\" data-ts=\"1494512456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266501-wells-fargominus-2_5-on-missed-efficiency-ratio-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo -2.5% on missed efficiency ratio target</a></h4><ul><li>In <a href=\"https://www08.wellsfargomedia.com/assets/pdf/about/investor-relations/presentations/2017/financial-presentation.pdf\" target=\"_blank\">slides for its Investor Day</a>, Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color='red'>-2.5%</font>) expects its 2017 efficiency ratio to be 60%-61% vs. the targeted range of 55%-59%. The bank takes note of lower loan growth and higher funding costs, and settlement-related expenses and lower revenue growth as a result of the account-opening scandal.</li><li>ROE continues at the lower end of the 11%-14% targeted range, as does ROA at the lower end of its 1.1%-1.4% targeted range.</li><li>Not standing still, the bank is targeting $2B in expense reductions by year-end 2018, with another $2B for the end of 2019.</li><li><a href=\"https://www.wellsfargo.com/about/investor-relations/events/2017-investor-day/\" target=\"_blank\">Webcast and all slide presentations</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3266501\" data-linked=\"Wells Fargo -2.5% on missed efficiency ratio target\" data-tweet=\"$WFC - Wells Fargo -2.5% on missed efficiency ratio target https://seekingalpha.com/news/3266501-wells-fargominus-2_5-on-missed-efficiency-ratio-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3266501-wells-fargominus-2_5-on-missed-efficiency-ratio-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266495\" data-ts=\"1494511625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGLD\" target=\"_blank\">RGLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266495-royal-goldplus-3-after-strong-fq3-results-record-operating-cash-flow\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Royal Gold +3% after strong FQ3 results, record operating cash flow</a></h4><ul>     <li>Royal Gold (<a href='https://seekingalpha.com/symbol/RGLD' title='Royal Gold, Inc.'>RGLD</a> <font color='green'>+3.3%</font>) rockets higher in early trading after reporting better than expected <a href=\"https://seekingalpha.com/news/3266230-royal-gold-beats-0_01-misses-revenue\" target=\"_blank\">FQ3 earnings</a> and revenues, as well as record operating cash flow of $76M, up 15% Y/Y.</li><li>Revenues rose 14% Y/Y, as higher sales from the Mount Milligan and Pueblo Viejo streams more than offset lower sales from the Andacollo stream, which was due to timing of concentrate shipments.</li><li>RGLD says FQ3 stream gold purchases totaled ~50K oz. with sales of 58K oz., and stream silver  purchases were ~374K oz. with sales of 322K oz.</li><li>RGLD says it had 15K gold  oz. and 375K silver oz. in inventory at the end of the quarter, vs. 24K gold oz. and  323K silver oz. in inventory at year-end 2016.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266495\" data-linked=\"Royal Gold +3% after strong FQ3 results, record operating cash flow\" data-tweet=\"$RGLD - Royal Gold +3% after strong FQ3 results, record operating cash flow https://seekingalpha.com/news/3266495-royal-goldplus-3-after-strong-fq3-results-record-operating-cash-flow?source=tweet\" data-url=\"https://seekingalpha.com/news/3266495-royal-goldplus-3-after-strong-fq3-results-record-operating-cash-flow\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266494\" data-ts=\"1494511417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPG\" target=\"_blank\">SPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266494-retail-landlords-under-pressure-following-weak-macys-kohls-numbers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail landlords under pressure following weak Macy&#39;s, Kohl&#39;s numbers</a></h4><ul><li>Macy's is&nbsp;<font color='red'>lower by more than 10%</font>, and Kohl's by&nbsp;<font color='red'>more than 5%&nbsp;</font>after each produced weak sales reports. Those numbers <a href=\"https://seekingalpha.com/news/3266489-mall-stocks-fall-sales-dud-macys\" target=\"_blank\">are hitting the entire department store sector</a>, and in turn, the companies from which they rent space.</li><li>Simon Property (<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a> <font color='red'>-2.7%</font>), General Growth (GGP <font color='red'>-2.3%</font>), Kimco (<a href='https://seekingalpha.com/symbol/KIM' title='Kimco Realty Corporation'>KIM</a> <font color='red'>-2.3%</font>), Weingarten (<a href='https://seekingalpha.com/symbol/WRI' title='Weingarten Realty Investors'>WRI</a> <font color='red'>-2.2%</font>), Macerich (<a href='https://seekingalpha.com/symbol/MAC' title='Macerich Co.'>MAC</a> <font color='red'>-2.4%</font>), Taubman (<a href='https://seekingalpha.com/symbol/TCO' title='Taubman Centers, Inc.'>TCO</a> <font color='red'>-2.3%</font>), PREIT (<a href='https://seekingalpha.com/symbol/PEI' title='Pennsylvania Real Estate Investment Trust'>PEI</a> <font color='red'>-2.9%</font>), DDR (DDR <font color='red'>-2.7%</font>), Tanger (<a href='https://seekingalpha.com/symbol/SKT' title='Tanger Factory Outlet Centers, Inc.'>SKT</a> <font color='red'>-2.3%</font>), Regency (<a href='https://seekingalpha.com/symbol/REG' title='Regency Centers Corporation'>REG</a> <font color='red'>-2.3%</font>), CBL (<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a> <font color='red'>-2.1%</font>), Washington Prime (<a href='https://seekingalpha.com/symbol/WPG' title='Washington Prime Group, Inc.'>WPG</a> <font color='red'>-1.8%</font>).</li><li>The triple-net lease players don't exactly rent space to the department store giants, but are subject to at least some of the same economic forces. Realty Income (<a href='https://seekingalpha.com/symbol/O' title='Realty Income Corporation'>O</a> <font color='red'>-1.7%</font>), National Retail (<a href='https://seekingalpha.com/symbol/NNN' title='National Retail Properties, Inc.'>NNN</a> <font color='red'>-2.8%</font>), Vereit (<a href='https://seekingalpha.com/symbol/VER' title='VEREIT Inc.'>VER</a> <font color='red'>-1.6%</font>), Spirit Realty (<a href='https://seekingalpha.com/symbol/SRC' title='Spirit Realty Capital'>SRC</a> <font color='red'>-3%</font>), Agree Realty (<a href='https://seekingalpha.com/symbol/ADC' title='Agree Realty Corporation'>ADC</a> <font color='red'>-1.6%</font>), Store Capital (<a href='https://seekingalpha.com/symbol/STOR' title='STORE Capital'>STOR</a> <font color='red'>-1.8%</font>)</li><li>The iShares U.S. Real Estate ETF (<a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a> <font color='red'>-1.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3266494\" data-linked=\"Retail landlords under pressure following weak Macy&#39;s, Kohl&#39;s numbers\" data-tweet=\"$SPG $SPG $BPR - Retail landlords under pressure following weak Macy&#39;s, Kohl&#39;s numbers https://seekingalpha.com/news/3266494-retail-landlords-under-pressure-following-weak-macys-kohls-numbers?source=tweet\" data-url=\"https://seekingalpha.com/news/3266494-retail-landlords-under-pressure-following-weak-macys-kohls-numbers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>119&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266489\" data-ts=\"1494510877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266489-mall-stocks-fall-after-sales-dud-from-macys\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mall stocks fall after sales dud from Macy&#39;s</a></h4><ul> <li>A double dose of weak sales reports from Macy's (<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a> <font color='red'>-11.9%</font>) and Kohl's (<a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a> <font color='red'>-5.6%</font>) has the entire department store sector jittery, and is taking along some mall names on a downward path.</li><li>It's the same story in general for the sector, with the cycle of weak store traffic and promotional activity hammering profitability.</li> <li>Notable decliners include Dillard's (<a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a> <font color='red'>-10.6%</font>), Sears Canada (<a href='https://seekingalpha.com/symbol/SRSC' title='Sears Canada Inc.'>SRSC</a>), Nordstrom (<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a> <font color='red'>-7.9%</font>), J.C. Penney (<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='red'>-7.3%</font>), Gap (<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='red'>-3.2%</font>), Express (<a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a> <font color='red'>-4.7%</font>), Guess (<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='red'>-4.4%</font>), Buckle (<a href='https://seekingalpha.com/symbol/BKE' title='The Buckle, Inc.'>BKE</a> <font color='red'>-4.7%</font>), American Eagle Outfitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='red'>-4.6%</font>), Urban Outfitters (<a href='https://seekingalpha.com/symbol/URBN' title='Urban Outfitters, Inc.'>URBN</a> <font color='red'>-4.9%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3266401-macys-misses-0_10-misses-revenue\" target=\"_blank\">Macy's misses by $0.10, misses on revenue</a> (May 11)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3266413-macys-falls-weak-sales-trend-continues\" target=\"_blank\">Macy's falls as weak sales trend continues</a> (May 11)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3266489\" data-linked=\"Mall stocks fall after sales dud from Macy&#39;s\" data-tweet=\"$M $M $KSS - Mall stocks fall after sales dud from Macy&#39;s https://seekingalpha.com/news/3266489-mall-stocks-fall-after-sales-dud-from-macys?source=tweet\" data-url=\"https://seekingalpha.com/news/3266489-mall-stocks-fall-after-sales-dud-from-macys\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266482\" data-ts=\"1494509708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENB\" target=\"_blank\">ENB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266482-enbridges-q1-hurt-liquids-pipeline-unit-sees-strong-full-year-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enbridge&#39;s Q1 hurt by liquids pipeline unit but sees strong full-year profit</a></h4><ul>     <li>Enbridge (<a href='https://seekingalpha.com/symbol/ENB' title='Enbridge Inc.'>ENB</a> <font color='red'>-2.9%</font>) opens lower after reporting adjusted <a href=\"https://seekingalpha.com/news/3266344-enbridge-beats-0_14\" target=\"_blank\">Q1 earnings</a> of C$0.57, below the analyst consensus estimate of C$0.62, hurt by lower earnings from its liquids pipeline business, which fell 10% Y/Y to C$970M.</li>     <li>ENB <a href=\"http://www.reuters.com/article/us-enbridge-inc-results-idUSKBN1871E3\" target=\"_blank\">forecasts a big rise in adjusted EBIT</a> for FY 2017 to C$7.2B-C$7.6B vs. C$4.7B earned last year before the acquisition of rival Spectra Energy; but it expects available cash flow per share from operations this year to fall to C$3.60-C$3.90 from C$4.08 in 2016.</li><li>Meanwhile, Energy Energy Partners (<a href='https://seekingalpha.com/symbol/EEP' title='Enbridge Energy Partners L.P.'>EEP</a> <font color='red'>-0.4%</font>) posts better than expected <a href=\"https://seekingalpha.com/news/3266238-enbridge-energy-partners-beats-0_09-beats-revenue\" target=\"_blank\">Q1 earnings</a> and revenues, and says it is on track to meet the 2017 financial outlook provided in January.</li><li>EEP says Q1 Lakehead system deliveries reached a record 2.74M bbl/day, and higher Mainline volumes partially offset continued weakness in the natural gas business and  lower average transportation rates and volumes on the North Dakota  system.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266482\" data-linked=\"Enbridge&#39;s Q1 hurt by liquids pipeline unit but sees strong full-year profit\" data-tweet=\"$ENB $ENB $EEP - Enbridge&#39;s Q1 hurt by liquids pipeline unit but sees strong full-year profit https://seekingalpha.com/news/3266482-enbridges-q1-hurt-liquids-pipeline-unit-sees-strong-full-year-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3266482-enbridges-q1-hurt-liquids-pipeline-unit-sees-strong-full-year-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266479\" data-ts=\"1494509400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266479-treatment-lexicons-sotagliflozin-trimmed-weight-and-reduced-blood-pressure-in-late-stage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Treatment with Lexicon&#39;s sotagliflozin trimmed weight and reduced blood pressure in late-stage study</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/16829723-lexicon-pharmaceuticals-reports-additional-positive-data-pivotal-intandem1-phase-3-study\" target=\"_blank\">Additional data </a>from Lexicon Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) Phase 3 Tandem1 study assessing sotagliflozin in type 1 diabetics showed treatment with the SGLT 1 &amp; 2 inhibitor reduced body weight up to 2.7 kg and lowered blood pressure in hypertensive patients. Both effects were statistically significant compared to placebo.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume.</li><li>Sanofi owns global rights for both type 1 and type 2 diabetes.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3207880-lexicons-sotagliflozin-successful-late-stage-study-shares-18-percent-premarket\" target=\"_blank\">Lexicon's sotagliflozin successful in late-stage study; shares up 18% premarket</a> (Sept. 9, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3266479\" data-linked=\"Treatment with Lexicon&#39;s sotagliflozin trimmed weight and reduced blood pressure in late-stage study\" data-tweet=\"$LXRX - Treatment with Lexicon&#39;s sotagliflozin trimmed weight and reduced blood pressure in late-stage study https://seekingalpha.com/news/3266479-treatment-lexicons-sotagliflozin-trimmed-weight-and-reduced-blood-pressure-in-late-stage?source=tweet\" data-url=\"https://seekingalpha.com/news/3266479-treatment-lexicons-sotagliflozin-trimmed-weight-and-reduced-blood-pressure-in-late-stage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266472\" data-ts=\"1494508877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266472-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li>ITUS <font color='red'>-41%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16830038-itus-corporation-announces-pricing-public-offering-3_5-million-shares-common-stock\" target=\"_blank\">pricing</a> public offering of 3.5M common shares.</li><li><a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>&nbsp;<font color='red'>-23%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3266017-snap-eps-2_31\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a>&nbsp;<font color='red'>-20%</font>&nbsp;on AT&amp;T backing out of <a href=\"https://seekingalpha.com/news/3266365-straight-path-plunges-20-percent-and-t-pulls-bidding\" target=\"_blank\">bidding</a>.</li><li><a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a>&nbsp;<font color='red'>-18</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3266024-mannkind-misses-0_08-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a>&nbsp;<font color='red'>-18%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3266446-conatus-pharma-readies-equity-offering-shares-18-percent-premarket\" target=\"_blank\">announcing</a> pending public offering.</li><li><a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='red'>-15%</font>.</li><li><a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a>&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3266364-superconductor-technologies-beats-0_01\" target=\"_blank\">Q1 earrnings</a>.</li><li><a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>&nbsp;<font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3266401-macys-misses-0_10-misses-revenue\" target=\"_blank\">Q1 earnings</a>&nbsp;miss.</li><li><a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a>&nbsp;<font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3266023-neovasc-misses-0_02-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a>&nbsp;<font color='red'>-11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3266387-gun-stocks-watch-weak-guidance-vista-outdoor\" target=\"_blank\">lower guidance</a>.</li><li><a href='https://seekingalpha.com/symbol/PIRS' title='Pieris Pharmaceuticals, Inc.'>PIRS</a>&nbsp;<font color='red'>-10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3266206-pieris-pharmaceuticals-reports-q1-results\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/NYRT' title='New York REIT'>NYRT</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>&nbsp;<font color='red'>-7%</font>&nbsp;on below consensus <a href=\"https://seekingalpha.com/news/3266117-dim-guidance-presses-symantec-minus-5_6-percent\" target=\"_blank\">guidance</a>.</li><li><a href='https://seekingalpha.com/symbol/ABR' title='Arbor Realty Trust, Inc.'>ABR</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3266439-arbor-realty-7-percent-pricing-secondary\" target=\"_blank\">pricing</a> secondary offering.</li><li><a href='https://seekingalpha.com/symbol/MZOR' title='Mazor Robotics Ltd.'>MZOR</a>&nbsp;<font color='red'>-6%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3266399-premarket-analyst-action-healthcare\" target=\"_blank\">downgraded</a> by Wells Fargo.</li><li><a href='https://seekingalpha.com/symbol/SP' title='SP Plus Corporation'>SP</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/HOLX' title='Hologic, Inc.'>HOLX</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3266027-hologic-beats-0_04-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3266472\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$ANIX $SNAP $STRP - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3266472-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3266472-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266468\" data-ts=\"1494508484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266468-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color='green'>+43%</font>.</li><li><a href='https://seekingalpha.com/symbol/DEST' title='Destination Maternity Corporation'>DEST</a> <font color='green'>+14%</font>.</li><li><a href='https://seekingalpha.com/symbol/LPSN' title='LivePerson, Inc.'>LPSN</a><font color='green'>+10%</font>. on Q1 result.</li><li><a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a>&nbsp;<font color='green'>+6%</font>. on Q1 <a href=\"https://seekingalpha.com/news/3266284-himax-technologies-misses-0_02-misses-revenue\" target=\"_blank\">result</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266468\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$SGMO $DEST $LPSN - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3266468-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3266468-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266467\" data-ts=\"1494508477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSK\" target=\"_blank\">GSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266467-fda-rejects-hikma-pharmaceuticals-marketing-application-for-generic-advair\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA rejects Hikma Pharmaceuticals&#39; marketing application for generic Advair</a></h4><ul><li>GlaxoSmithKline (NYSE:<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a>) has sidestepped generic competition to asthma and COPD med Advair (fluticasone propionate/salmeterol) in the U.S. a second time after the FDA <a href=\"http://www.reuters.com/news/health\" target=\"_blank\">rejected</a> Hikma Pharmaceuticals' application to market a generic version. In March, the agency turned down Mylan's application.</li><li>In Q1, Advair's U.S. sales accounted for 45% of its global total of \u20a4752M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3254222-mylans-generic-version-gsks-advair-rejected-fda-shares-2-percent\" target=\"_blank\">Mylan's generic version of GSK's Advair rejected by FDA; shares down 2%</a> (March 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3266467\" data-linked=\"FDA rejects Hikma Pharmaceuticals&#39; marketing application for generic Advair\" data-tweet=\"$GSK - FDA rejects Hikma Pharmaceuticals&#39; marketing application for generic Advair https://seekingalpha.com/news/3266467-fda-rejects-hikma-pharmaceuticals-marketing-application-for-generic-advair?source=tweet\" data-url=\"https://seekingalpha.com/news/3266467-fda-rejects-hikma-pharmaceuticals-marketing-application-for-generic-advair\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266465\" data-ts=\"1494508265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PED\" target=\"_blank\">PED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266465-pedevcoplus-35-after-regaining-nyse-listing-compliance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pedevco +35% after regaining NYSE listing compliance</a></h4><ul><li>Pedevco (NYSEMKT:<a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a>) <font color='green'>+35%</font> premarket after <a href=\"https://seekingalpha.com/filing/3543838\" target=\"_blank\">disclosing</a> that it regained  compliance with the NYSE MKT's 30-day average closing price per  share requirement.</li><li>PED says it is working to complete one of several  potential deals that could significantly increase stockholders equity  well above NYSE's minimum continued listing standards.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266465\" data-linked=\"Pedevco +35% after regaining NYSE listing compliance\" data-tweet=\"$PED - Pedevco +35% after regaining NYSE listing compliance https://seekingalpha.com/news/3266465-pedevcoplus-35-after-regaining-nyse-listing-compliance?source=tweet\" data-url=\"https://seekingalpha.com/news/3266465-pedevcoplus-35-after-regaining-nyse-listing-compliance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266460\" data-ts=\"1494507853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWH\" target=\"_blank\">SPWH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266460-sportsmans-warehouse-lower-after-vista-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sportsman&#39;s Warehouse lower after Vista warning</a></h4><ul> <li>Shares of Sportsman's Warehouse Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a>)&nbsp;are on watch after peer Visto Outdoors reports slumping demand for guns and ammunition.</li> <li>In light premarket action, SPWH is <font color='red'>down 2.95%</font> to $4.60.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3266334-vista-outdoor-misses-0_14-beats-revenue\" target=\"_blank\">Vista Outdoor misses by $0.14, beats on revenue</a> (May 11)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3266387-gun-stocks-watch-weak-guidance-vista-outdoor\" target=\"_blank\">Gun stocks on watch after weak guidance from Vista Outdoor</a> (May 11)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3266460\" data-linked=\"Sportsman&#39;s Warehouse lower after Vista warning\" data-tweet=\"$SPWH - Sportsman&#39;s Warehouse lower after Vista warning https://seekingalpha.com/news/3266460-sportsmans-warehouse-lower-after-vista-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3266460-sportsmans-warehouse-lower-after-vista-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266459\" data-ts=\"1494507791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOBGF\" target=\"_blank\">NOBGF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266459-noble-group-sinks-to-15-year-lows-warns-may-not-be-profitable-until-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Group sinks to 15-year lows; warns it may not be profitable until 2019</a></h4><ul><li>Noble Group (<a href='https://seekingalpha.com/symbol/NOBGF' title='NOBLE GROUP LTD ORD NEW'>OTCPK:NOBGF</a>, <a href='https://seekingalpha.com/symbol/NOBGY' title='Noble Group Ltd. ADR'>OTCPK:NOBGY</a>) shares <a href=\"http://www.marketwatch.com/story/noble-group-shares-plunge-to-15-year-low-2017-05-11\" target=\"_blank\">plunge to 15-year lows</a> after the commodities supplier swung to a net Q1 loss of $129.3M, reversing a $40.5M profit in the year-earlier quarter.</li><li>Noble had <a href=\"https://seekingalpha.com/news/3265257-noble-group-warns-130m-q1-loss-dislocation-coal-markets\" target=\"_blank\">announced Tuesday</a> that it  expected to report a ~$130M net loss, citing a drop in coal  prices that upended its hedges and resulted in an exceptional loss.</li><li>Noble also says Paul Brough, a non-executive director, <a href=\"https://www.ft.com/content/57349d65-a598-3e91-919c-7e04fc1ff0c5\" target=\"_blank\">will replace</a> founder  Richard Elman as chairman and take charge of reviewing strategic options.</li><li>Elman says the company was on the right track but \"it will be a long, hard slog with ups and downs along the way, until we regain profitability, a goal that we are most likely to achieve in 2018-19.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3266459\" data-linked=\"Noble Group sinks to 15-year lows; warns it may not be profitable until 2019\" data-tweet=\"$NOBGF $NOBGF $NOBGY - Noble Group sinks to 15-year lows; warns it may not be profitable until 2019 https://seekingalpha.com/news/3266459-noble-group-sinks-to-15-year-lows-warns-may-not-be-profitable-until-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3266459-noble-group-sinks-to-15-year-lows-warns-may-not-be-profitable-until-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266446\" data-ts=\"1494507093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNAT\" target=\"_blank\">CNAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266446-conatus-pharma-readies-equity-offering-shares-down-18-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conatus Pharma readies equity offering; shares down 18% premarket</a></h4><ul><li>Conatus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a>) slumps&nbsp;<font color='red'>18%</font>&nbsp;premarket on average volume in response to its pending <a href=\"https://seekingalpha.com/pr/16829154-conatus-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering</a> of common stock. Price, volume and terms have yet to be announced.</li><li>Net proceeds will fund pipeline expansion and provide an exit for Advent Private Equity by virtue of purchasing 2,166,836 shares of common stock currently held by the investor.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266446\" data-linked=\"Conatus Pharma readies equity offering; shares down 18% premarket\" data-tweet=\"$CNAT - Conatus Pharma readies equity offering; shares down 18% premarket https://seekingalpha.com/news/3266446-conatus-pharma-readies-equity-offering-shares-down-18-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3266446-conatus-pharma-readies-equity-offering-shares-down-18-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266439\" data-ts=\"1494506403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABR\" target=\"_blank\">ABR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266439-arbor-realty-down-7-after-pricing-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arbor Realty down 7% after pricing secondary</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/16830089-arbor-realty-trust-announces-pricing-public-offering-common-stock\" target=\"_blank\">company sold 9.5M shares</a> for gross proceeds of roughly $77.9M, suggesting a price of $8.20 each. The underwriters have an option buy another 1.425M shares at that price.</li><li>Again, Arbor is in the process of buying out its external manager, and at least some of the money raised will be used to fund that.</li><li><a href='https://seekingalpha.com/symbol/ABR' title='Arbor Realty Trust, Inc.'>ABR</a>&nbsp;<font color='red'>-6.9%</font>&nbsp;to $8.14</li></ul><div class=\"tiny-share-widget\" data-id=\"3266439\" data-linked=\"Arbor Realty down 7% after pricing secondary\" data-tweet=\"$ABR - Arbor Realty down 7% after pricing secondary https://seekingalpha.com/news/3266439-arbor-realty-down-7-after-pricing-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/3266439-arbor-realty-down-7-after-pricing-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266440\" data-ts=\"1494506403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266440-guidance-e-l-f-beauty-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guidance at e.l.f. Beauty disappoints</a></h4><ul> <li>Shares of e.l.f. Beauty (NYSE:<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a>) are on watch after the cosmetics company tops <a href=\"https://seekingalpha.com/pr/16829198-e-l-f-beauty-announces-first-quarter-2017-results\" target=\"_blank\">profit estimates</a> and reaffirms its guidance for 2017.</li> <li>The company expects sales growth to $285M to $290M in 2017, which although it implies a sizzling pace, misses the consenus estimate of $291.3M at the mid-point.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3266066-e-l-f-beauty-beats-0_04-beats-revenue\" target=\"_blank\">e.l.f. Beauty beats by $0.04, beats on revenue</a> (May 10)</li> <li>ELF <font color='red'>-5.43%</font> premarket to $27.50 vs. a 52-week trading range of $23.73 to $32.54.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3266440\" data-linked=\"Guidance at e.l.f. Beauty disappoints\" data-tweet=\"$ELF - Guidance at e.l.f. Beauty disappoints https://seekingalpha.com/news/3266440-guidance-e-l-f-beauty-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3266440-guidance-e-l-f-beauty-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266438\" data-ts=\"1494506372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266438-bofa-upgrades-cat-on-sales-momentum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofA upgrades CAT on sales momentum</a></h4><ul><li>BofA/Merrill Lynch raises Caterpillar (NYSE:<a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a>) to Buy from Neutral, saying monthly retail sales continue to accelerate.</li><li>Another \"big beat and raise\" may happen in July and the dividend can be increased over the summer.</li><li>The firm also raised its price target on the stock to $120 from $105.</li><li><a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color='green'>+1%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3266438\" data-linked=\"BofA upgrades CAT on sales momentum\" data-tweet=\"$CAT - BofA upgrades CAT on sales momentum https://seekingalpha.com/news/3266438-bofa-upgrades-cat-on-sales-momentum?source=tweet\" data-url=\"https://seekingalpha.com/news/3266438-bofa-upgrades-cat-on-sales-momentum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266432\" data-ts=\"1494506075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266432-oragenics-inks-direct-placement-of-convertible-preferred-stock-0_25-shares-down-12-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oragenics inks direct placement of convertible preferred stock at $0.25; shares down 12% premarket</a></h4><ul><li>Thinly traded nano cap Oragenics (NYSEMKT:<a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a>) slips&nbsp;<font color='red'>12%</font>&nbsp;premarket, albeit on only 1,000 shares, in response to its <a href=\"https://seekingalpha.com/pr/16829878-oragenics-announces-3_0-million-preferred-stock-private-placement-2_4-million-loan\" target=\"_blank\">announcement </a>that it will sell up to $3M of Series A convertible preferred stock to three investor at $0.25 per share. The shares are convertible anytime into common stock at $0.25. The sale will occur in two separate closings. The first was executed yesterday. The second is contingent on shareholder approval.</li><li>Investors also received warrants to purchase up to 4,621,037 common shares at the first closing and will receive warrants to purchase an additional 6,024,124 common shares at the second closing. They are valid for seven years and can be exercised at $0.31 per common share six months after issuance.</li><li>Concurrently, the company has borrowed $2.4M from Intrexon in the form of a two-year unsecured non-convertible promissory note that pays 12% simple interest annually. Proceeds will fund AG013 research and clinical trials. Oragenics and Intrexon have also agreed to amend the first milestone payment under their Exclusive Channel Collaboration Agreement from a $2M payment triggered by the first patient dosing to a $3M payment based on the earlier of the dosing of the last patient in a Phase 2 study or the 24-month anniversary of the dosing of the first patient in the study.</li><li>Yesterday's close was $0.40.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266432\" data-linked=\"Oragenics inks direct placement of convertible preferred stock at $0.25; shares down 12% premarket\" data-tweet=\"$OGEN - Oragenics inks direct placement of convertible preferred stock at $0.25; shares down 12% premarket https://seekingalpha.com/news/3266432-oragenics-inks-direct-placement-of-convertible-preferred-stock-0_25-shares-down-12-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3266432-oragenics-inks-direct-placement-of-convertible-preferred-stock-0_25-shares-down-12-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266428\" data-ts=\"1494505934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SES\" target=\"_blank\">SES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266428-synthesis-energyplus-26-on-technology-license-pact-in-australia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synthesis Energy +26% on technology license pact in Australia</a></h4><ul>     <li>Synthesis Energy Systems (SYMX) <font color='green'>+25.8%</font> premarket after announcing a <a href=\"https://seekingalpha.com/pr/16829754-synthesis-energy-systems-inc-secures-technology-license-agreement-project-australia\" target=\"_blank\">technology license agreement</a> with Australian Future Energy for a large-scale project in Australia.</li>     <li>SYMX says it expects to receive fees based on the licensed capacity for the project and for the process design package totaling $27M, and for the entire package of technology, services and equipment to provide top line revenue of ~$150M.</li>     <li>The project is expected to be the first of several developed by AFE for industrial-scale poly-generation facilities that produce low-cost syngas, ammonia for nitrogen fertilizer and ammonium nitrate  products, as well as synthetic natural gas and electric power.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266428\" data-linked=\"Synthesis Energy +26% on technology license pact in Australia\" data-tweet=\"$SES - Synthesis Energy +26% on technology license pact in Australia https://seekingalpha.com/news/3266428-synthesis-energyplus-26-on-technology-license-pact-in-australia?source=tweet\" data-url=\"https://seekingalpha.com/news/3266428-synthesis-energyplus-26-on-technology-license-pact-in-australia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266413\" data-ts=\"1494505069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266413-macys-falls-weak-sales-trend-continues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macy&#39;s falls as weak sales trend continues</a></h4><ul> <li>Macy's (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>) reports comparable sales fell 4.6% on an owned plus licensed basis in <a href=\"https://seekingalpha.com/pr/16829920-macy-s-inc-reports-first-quarter-earnings\" target=\"_blank\">Q1</a> to miss the consensus estimate for a 3.5% decline.</li> <li>Gross margin was 38.1% of sales vs. 39.1% a year ago and 38.8% expected.</li> <li>SG&amp;A expenses fell 10 bps to 34.0% of sales.</li> <li>Operating income dropped 70 bps to 4.1% of sales.</li> <li>\"We are encouraged by the performance of the pilot programs we tested last year in categories like women&rsquo;s shoes, fine jewelry, and furniture and mattresses,\" says CEO Jeff Gennette.</li><li>Macy's expects sales to fall 3.2% to 4.3% in FY17 and EPS to land in a range of $3.37 to $3.62.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3266401-macys-misses-0_10-misses-revenue\" target=\"_blank\">Macy's misses by $0.10, misses on revenue</a> (May 11)</li> <li>Shares of Macy's are <font color='red'>down 8.04%</font> premarket to $26.98.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266413\" data-linked=\"Macy&#39;s falls as weak sales trend continues\" data-tweet=\"$M - Macy&#39;s falls as weak sales trend continues https://seekingalpha.com/news/3266413-macys-falls-weak-sales-trend-continues?source=tweet\" data-url=\"https://seekingalpha.com/news/3266413-macys-falls-weak-sales-trend-continues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266408\" data-ts=\"1494504670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266408-valeant-and-mylan-perk-up-after-teva-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant and Mylan perk up after Teva earnings beat</a></h4><ul><li>Premarket buying, albeit modest, moves generic drug firms Valeant Pharmaceuticals (VRX) &nbsp;and Mylan N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a>) up&nbsp;<font color='green'>1%</font>&nbsp;on the heels of Teva's Q1 results released this morning. The company beat non-GAAP EPS and reaffirmed guidance for the year. It also stated that it expects to realize $1.5B in synergies and cost reductions by the end of 2017.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3266408\" data-linked=\"Valeant and Mylan perk up after Teva earnings beat\" data-tweet=\"$BHC $BHC $MYL - Valeant and Mylan perk up after Teva earnings beat https://seekingalpha.com/news/3266408-valeant-and-mylan-perk-up-after-teva-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3266408-valeant-and-mylan-perk-up-after-teva-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266388\" data-ts=\"1494503360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYN\" target=\"_blank\">SYN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266388-synthetic-bios-ribaxamase-breakthrough-therapy-for-prevention-of-c-diff-infection-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synthetic Bio&#39;s ribaxamase a Breakthrough Therapy for prevention of C. diff infection; shares ahead 30% premarket</a></h4><ul><li>Penny stock Synthetic Biologics (NYSEMKT:<a href='https://seekingalpha.com/symbol/SYN' title='Synthetic Biologics, Inc.'>SYN</a>) jumps&nbsp;<font color='green'>30%</font>&nbsp;premarket, albeit on only 3,900 shares, in response to its <a href=\"https://seekingalpha.com/pr/16829790-synminus-004-ribaxamase-receives-breakthrough-therapy-designation-u-s-food-drug\" target=\"_blank\">announcement </a>that the FDA has designated co-lead product candidate SYN-004 (ribaxamase) a Breakthrough Therapy for preventing <em>Clostridium difficile</em> (<em>C. diff</em>) infection.</li><li><a href=\"http://www.syntheticbiologics.com/product-pipeline/microbiome-focused-pipeline/syn-004-ribaxamase\" target=\"_blank\">Ribaxamase&nbsp;</a>is a first-in-class oral enzyme designed to degrade certain IV beta-lactam antibiotics within the GI tract and maintain the natural balance of the gut microbiome. The next step in development should be a Phase 3 confirmatory study.</li><li>Breakthrough Therapy status provides for more intensive FDA guidance on the best development path, the involvement of more senior agency personnel and a rolling review of the New Drug Application &#40;NDA&#41;.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233592-synthetic-bios-co-lead-product-candidate-successful-mid-stage-study-shares-ahead-25-percent\" target=\"_blank\">Synthetic Bio's co-lead product candidate successful in mid-stage study; shares ahead 25% premarket</a> (Jan. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3266388\" data-linked=\"Synthetic Bio&#39;s ribaxamase a Breakthrough Therapy for prevention of C. diff infection; shares ahead 30% premarket\" data-tweet=\"$SYN - Synthetic Bio&#39;s ribaxamase a Breakthrough Therapy for prevention of C. diff infection; shares ahead 30% premarket https://seekingalpha.com/news/3266388-synthetic-bios-ribaxamase-breakthrough-therapy-for-prevention-of-c-diff-infection-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3266388-synthetic-bios-ribaxamase-breakthrough-therapy-for-prevention-of-c-diff-infection-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266387\" data-ts=\"1494503325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSTO\" target=\"_blank\">VSTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266387-gun-stocks-on-watch-after-weak-guidance-from-vista-outdoor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gun stocks on watch after weak guidance from Vista Outdoor</a></h4><ul> <li>Gun stocks are on watch after cautious comments from Vista Outdoor (NYSE:<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a>) CEO Mark DeYoung following his company's earnings report and light guidance.</li> <li>\"We are experiencing unprecedented decline in demand for ammunition and firearms following the presidential election and softness in the retail environment,\" warns DeYoung.</li> <li>Vista lowered expectations due to the weakness in the shooting sports market, guiding for FY18 sales of $2.36B to $2.42B vs. $2.43B consensus and EPS of $1.10 to $1.30.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3266334-vista-outdoor-misses-0_14-beats-revenue\" target=\"_blank\">Vista Outdoor misses by $0.14, beats on revenue</a> (May 11)</li> <li>Shares of Vista are <font color='red'>down 14.80%</font> premarket to $17.50. Sturm Ruger <font color='red'>-0.08%</font>. American Outdoor Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>) <font color='red'>-1.41%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266387\" data-linked=\"Gun stocks on watch after weak guidance from Vista Outdoor\" data-tweet=\"$VSTO $VSTO $AOBC - Gun stocks on watch after weak guidance from Vista Outdoor https://seekingalpha.com/news/3266387-gun-stocks-on-watch-after-weak-guidance-from-vista-outdoor?source=tweet\" data-url=\"https://seekingalpha.com/news/3266387-gun-stocks-on-watch-after-weak-guidance-from-vista-outdoor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266386\" data-ts=\"1494503285\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMF\" target=\"_blank\">OMF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266386-onemain-holdingsplus-0_75-after-two-notch-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OneMain Holdings +0.75% after two-notch upgrade</a></h4><ul><li>Impressed with Q1 results and expecting the company to be able to hit full-year core EPS guidance of $3.75-$4, BAML's Ken Bruce upgrades OneMain (NYSE:<a href='https://seekingalpha.com/symbol/OMF' title='OneMain Holdings, Inc.'>OMF</a>) to Buy from Underperform. He lifts his price target to $28 from $23, suggesting&nbsp;<font color='green'>18% upside</font>.</li><li>Shares&nbsp;<font color='green'>+0.75%</font>&nbsp;premarket to $23.87.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3263104-onemain-holdings-eps-0_25\" target=\"_blank\">OneMain Holdings EPS of $0.25</a> (May 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3266386\" data-linked=\"OneMain Holdings +0.75% after two-notch upgrade\" data-tweet=\"$OMF - OneMain Holdings +0.75% after two-notch upgrade https://seekingalpha.com/news/3266386-onemain-holdingsplus-0_75-after-two-notch-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3266386-onemain-holdingsplus-0_75-after-two-notch-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266384\" data-ts=\"1494503212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WRD\" target=\"_blank\">WRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266384-wildhorse-to-buy-eagle-ford-acreage-from-anadarko-kkr-for-625m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WildHorse to buy Eagle Ford acreage from Anadarko, KKR for $625M</a></h4><ul>     <li>WildHorse Resource Development (NYSE:<a href='https://seekingalpha.com/symbol/WRD' title='WildHorse Resource Development'>WRD</a>)&nbsp;<font color='green'>+2%</font> premarket after <a href=\"https://seekingalpha.com/pr/16829711-wildhorse-resource-development-corporation-announces-strategic-acquisition-eagle-ford\" target=\"_blank\">agreeing to acquire</a> 111K net acres in the Eagle Ford and  associated production from Anadarko Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a>) and <a href='https://seekingalpha.com/symbol/KKR' title='KKR'>KKR</a> for $625M.</li>     <li>In conjunction with the deal, Carlyle Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CG' title='The Carlyle Group'>CG</a>) agrees to purchase $435M of convertible preferred stock from WRD.</li>     <li>WRD says Q4 net production on the acquired properties was 7,583 boe/day, consisting of 72% oil from 386 operated wells.</li>     <li>WRD&nbsp;raises its estimated FY 2017 production guidance range to 27K-31K boe/day from 23K-27K previously, with three-quarters of the increase due to the acquired  production; 2017 capex guidance is increased to $550M-$675M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3266384\" data-linked=\"WildHorse to buy Eagle Ford acreage from Anadarko, KKR for $625M\" data-tweet=\"$WRD $WRD $APC - WildHorse to buy Eagle Ford acreage from Anadarko, KKR for $625M https://seekingalpha.com/news/3266384-wildhorse-to-buy-eagle-ford-acreage-from-anadarko-kkr-for-625m?source=tweet\" data-url=\"https://seekingalpha.com/news/3266384-wildhorse-to-buy-eagle-ford-acreage-from-anadarko-kkr-for-625m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266375\" data-ts=\"1494502483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266375-teva-q1-top-line-up-17-generics-up-24-earnings-up-2-cash-flow-down-66-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva Q1 top line up 17%; generics up 24%; earnings up 2%; cash flow down 66%; shares ahead 2% premarket</a></h4><ul><li>Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) <a href=\"https://seekingalpha.com/pr/16829788-teva-reports-first-quarter-2017-financial-results\" target=\"_blank\">Q1 results</a> ($M): Total Revenues: 5,630 (+17.0%), Generic Medicines: 3,058 (+24.4%), Specialty Medicines: 2,020 (-6.1%), Multiple Sclerosis: 970 (-3.6%), Other Specialty: 1,050 (+2.9%).</li><li>Net Income: 580 (+1.8%); Non-GAAP Net Income: 1,079 (-7.9%); EPS: 0.57 (-8.1%); Non-GAAP EPS: 1.06 (-11.7%); Cash Flow Ops: 470 (-65.8%).</li><li>Key Product Sales: CNS: 2,168 (-11.2%); Copaxone: 1,138 (-14.0%); Respiratory: 425 (-21.2%); Treanda &amp; Bendeka: 157 (+1.3%); Women's Heath: 124 (+12.7%).</li><li>Copaxone sales in U.S.: 782 (-5%) due to lower volumes partially offset by a 7.9% price increase for both products in January 2017.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3266375\" data-linked=\"Teva Q1 top line up 17%; generics up 24%; earnings up 2%; cash flow down 66%; shares ahead 2% premarket\" data-tweet=\"$TEVA - Teva Q1 top line up 17%; generics up 24%; earnings up 2%; cash flow down 66%; shares ahead 2% premarket https://seekingalpha.com/news/3266375-teva-q1-top-line-up-17-generics-up-24-earnings-up-2-cash-flow-down-66-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3266375-teva-q1-top-line-up-17-generics-up-24-earnings-up-2-cash-flow-down-66-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266365\" data-ts=\"1494501725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266365-straight-path-plunges-20-after-and-t-pulls-out-of-bidding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Straight Path plunges 20% after AT&amp;T pulls out of bidding</a></h4><ul><li>It's official now: Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a>) will buy Straight Path (NYSEMKT:<a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a>) for <a href=\"https://seekingalpha.com/pr/16829739-verizon-enter-definitive-agreement-acquire-straight-path-communications-184_00-per-share\" target=\"_blank\">$184 per share in an all-stock deal</a>. AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) will receive a $38M termination fee.</li><li>The price represents a&nbsp;<font color='green'>404% premium</font>&nbsp;to the close on April 7 - the day before the announcement of the AT&amp;T agreement, but is substantially less than STRP's close last night of $223.79.</li><li>STRP<font color='red'> -20.5%</font>&nbsp;to $178, VZ&nbsp;<font color='red'>-0.75%</font>&nbsp;premarket</li><li>Previously: <a href=\"https://seekingalpha.com/news/3266247-wsj-verizon-wins-straight-path-sweepstakes-3_1b-buyout-deal\" target=\"_blank\">WSJ: Verizon wins Straight Path sweepstakes with $3.1B buyout deal</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3266365\" data-linked=\"Straight Path plunges 20% after AT&amp;T pulls out of bidding\" data-tweet=\"$VZ $VZ $STRP - Straight Path plunges 20% after AT&amp;T pulls out of bidding https://seekingalpha.com/news/3266365-straight-path-plunges-20-after-and-t-pulls-out-of-bidding?source=tweet\" data-url=\"https://seekingalpha.com/news/3266365-straight-path-plunges-20-after-and-t-pulls-out-of-bidding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3266363\" data-ts=\"1494501571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALO\" target=\"_blank\">ALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3266363-timmins-gold-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Timmins Gold beats by $0.01, beats on revenue</a></h4><ul><li>Timmins Gold (TGD): Q1 EPS of $0.02 <font color='green'>beats by $0.01</font>.</li><li>Revenue of $32.31M (+12.9% Y/Y) <font color='green'>beats by $4.31M</font>.</li><li>Shares <font color='green'>+1.78%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16829829-timmins-gold-alio-gold-announces-q1-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3266363\" data-linked=\"Timmins Gold beats by $0.01, beats on revenue\" data-tweet=\"$ALO - Timmins Gold beats by $0.01, beats on revenue https://seekingalpha.com/news/3266363-timmins-gold-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3266363-timmins-gold-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":71,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}